NVST - Envista Holdings Corp
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$28.20
DETAILS
HIGH:
$35.00
LOW:
$19.00
MEDIAN:
$29.00
CONSENSUS:
$28.20
UPSIDE:
8.84%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Greenblatt | 2,291,134 | $58.1M | 0.2% | +876,634 | INCREASED |
| Dalio | 76,437 | $1.9M | 0.0% | -47,660 | DECREASED |
| Cooperman | 17,292 | $438,699 | 0.0% | -35,133 | DECREASED |
| Wood | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-25 | Keel Paul A | director, officer: Chief Executive Officer | F-InKind | 12,811 | $23.43 | $300K |
| 2026-05-19 | Jain Vivek | director | A-Award | 9,330 | -- | -- |
| 2026-05-19 | Pierce James Andrew | director | A-Award | 9,330 | -- | -- |
| 2026-05-19 | Raskas Daniel | director | A-Award | 9,330 | -- | -- |
| 2026-05-19 | Carruthers Wendy | director | A-Award | 9,330 | -- | -- |
| 2026-05-19 | Huennekens R Scott | director | A-Award | 12,585 | -- | -- |
| 2026-05-19 | TSINGOS CHRISTINE A | director | A-Award | 9,330 | -- | -- |
| 2026-05-19 | GALLAHUE KIERAN | director | A-Award | 9,330 | -- | -- |
| 2026-02-25 | Nilsson Stefan | officer: President, Nobel Biocare | A-Award | 18,020 | $29.59 | $533K |
| 2026-02-25 | Nilsson Stefan | officer: President, Nobel Biocare | A-Award | 13,845 | -- | -- |
| 2026-02-25 | Nance Mark E | officer: General Counsel | A-Award | 23,070 | -- | -- |
| 2026-02-25 | Nance Mark E | officer: General Counsel | A-Award | 12,675 | -- | -- |
| 2026-02-25 | Befidi Robert | officer: President, Diagnostics | A-Award | 13,845 | -- | -- |
| 2026-02-25 | Hammes Eric D. | officer: Chief Financial Officer | A-Award | 29,225 | -- | -- |
| 2026-02-25 | Acurio Veronica | officer: President, Orthodontics | A-Award | 13,845 | -- | -- |
| 2026-02-25 | Hammes Eric D. | officer: Chief Financial Officer | A-Award | 38,040 | $29.59 | $1.1M |
| 2026-02-25 | Nance Mark E | officer: General Counsel | F-InKind | 3,368 | $29.59 | $100K |
| 2026-02-25 | Kaabi Faez C | officer: Chief Accounting Officer | F-InKind | 4,964 | $29.59 | $147K |
| 2026-02-25 | Keel Paul A | director, officer: Chief Executive Officer | A-Award | 48,670 | -- | -- |
| 2026-02-25 | Keel Paul A | director, officer: Chief Executive Officer | F-InKind | 11,840 | $29.59 | $350K |
| 2026-02-25 | Keel Paul A | director, officer: Chief Executive Officer | A-Award | 115,320 | $29.59 | $3.4M |
| 2026-02-25 | Befidi Robert | officer: President, Diagnostics | A-Award | 7,605 | -- | -- |
| 2026-02-25 | Nance Mark E | officer: General Counsel | A-Award | 30,040 | $29.59 | $889K |
| 2026-02-25 | Befidi Robert | officer: President, Diagnostics | F-InKind | 2,177 | $29.59 | $64K |
| 2026-02-25 | Befidi Robert | officer: President, Diagnostics | A-Award | 18,020 | $29.59 | $533K |